| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $280.0M | — | +27.1% |
| Cost of Revenue | $120.7M | — | +23.7% |
| Gross Profit | $159.3M | — | +29.8% |
| R&D Expense | $54.6M | — | +24.3% |
| SG&A Expense | $28.4M | — | +6.3% |
| Operating Income | $12.7M | — | +309.1% |
| Pre-tax Income | $15.2M | — | +609.4% |
| Income Tax | $4.0M | — | +123.8% |
| Net Income | $11.2M | — | +334.2% |
| EPS (Basic) | $0.17 | — | +342.9% |
| EPS (Diluted) | $0.16 | — | +328.6% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $54.6M | -61.8% | +29.1% |
| Accounts Receivable | $116.8M | +17.5% | +54.6% |
| Inventory | $154.6M | +15.6% | +53.3% |
| Current Assets | $587.2M | -15.1% | +4.5% |
| Total Assets | $951.4M | -10.1% | +3.7% |
| Current Liabilities | $178.5M |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $14.6M | — | -15.0% |
| Capital Expenditures | $8.1M | — | +88.4% |
| Investing Cash Flow | $47.9M | — | +335.5% |
| Financing Cash Flow | -$150.9M | — | -417.9% |
| Free Cash Flow | $6.5M | — | -49.5% |
| +45.3% |
| Total Liabilities | $213.4M | +7.1% | +42.3% |
| Stockholders' Equity | $738.0M | -14.1% | -3.8% |